This month *Retrovirology*completes two years of continuous publishing. At the 24 months juncture, we are pleased with the support and traction that we have achieved within our scientific community. *Retrovirology*is now tracked and indexed in all major bibliographic services including *Medline*, *PubMed*, *Embase*, and *Thomson ISI*; and citations in the literature to *Retrovirology*papers are increasingly numerous.

To our knowledge, we are the only journal focused on retrovirus research that is *Open Access*. Is that important? You bet! When you consider that we are a tightly focused publication serving a numerically small community, and you realize that *Retrovirology*is being accessed over 1740 times each week day and 1670 times each weekend day, then I believe you can appreciate the real demand for and the power of *Open Access*. As science moves increasingly toward globalization, *Retrovirology*embraces the timely and necessary concept that we have a responsibility to distribute scientific knowledge using an access model that transcends professional classifications, national boundaries, individual wealth, and accidents of birth.

In keeping with *Retrovirology\'s*goal to highlight high quality stringently reviewed science and to bring visibility to retrovirus research, the journal sponsors an annual *Retrovirology*Prize.

Nominations are being called for the 2006 *Retrovirology*Prize
==============================================================

Last year *Retrovirology*began an annual prize to recognize an outstanding retrovirologist between the ages of 45 to 60 \[[@B1]\]. The *Retrovirology*Prize consists of an attractive crystal trophy (Figure [1](#F1){ref-type="fig"}), a \$3,000 cash award, and a profile article of the winner published in *Retrovirology*about his/her scientific contributions to retrovirus research. The *Retrovirology*Prize is supported in part through a donation from the Ming K. Jeang Foundation (Figure [2](#F2){ref-type="fig"}), an educational foundation based in Houston, Texas, USA. Accordingly, the Prize is named the M. Jeang *Retrovirology*Prize.
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In 2005, Dr. Stephen P. Goff of Columbia University, USA, was our winner \[[@B2]\]. We anticipate selecting an equally outstanding and accomplished scientist for 2006.

The selection process
=====================

As stated previously \[[@B1]\], the Prize alternates yearly between recognizing a non-HIV retrovirologist (2005 and odd years) and an HIV retrovirologist (2006 and even years). There can be some discretion on this criterion exercised from time-to-time by the selection committee. Any individual can initiate a nomination of others or self-nominate. A nomination includes a statement (1000 words or less) of the nominee\'s significant contributions to retrovirus research; a curriculum vitae of the nominee, and a statement by the nominator that the nominee has agreed to be nominated. The selection committee consists of the Editors of *Retrovirology*(currently, M. Benkirane, B. Berkhout, M. Fujii, K.T. Jeang, M. Lairmore, A. Lever, and M. Wainberg). All nominations submitted to the selection committee must be communicated through an Editorial Board member of *Retrovirology*. Hence, any individual who is not an Editorial board member who wishes to make a nomination should seek out a *Retrovirology*Editorial board member to communicate his/her information to the selection committee. A list of current Editorial Board members can be found at the *Retrovirology*website <http://www.retrovirology.com>. Within stipulated age limits, all *Retrovirology*Editors and Editorial Board members are eligible to be nominated with the exception of the Editor-in-Chief who will administer the final selection decision.

For 2006, nominations will begin April 1^st^and will close June 1^st^. I urge all members of our scientific community to participate in this process for recognizing a deserving colleague.
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